Role of Galectins in Immunity and Disease

Displaying 1 - 8 of 8CSV
Lee, L. W., Shafiani, S., Crossley, B., Emerson, R. O., Williamson, D., Bunin, A., Vargas, J., Han, A. S., Kaplan, I. M., Green, P. H. R., Kirsch, I., & Bhagat, G. (2022). Characterisation of T cell receptor repertoires in coeliac disease. Journal of Clinical Pathology, 77(2), 116–124. https://doi.org/10.1136/jcp-2022-208541
Publication Date
Falchook, G., Rasco, D., Papadopoulos, K., Parikh, A., Mahipal, A., Messersmith, W., Manji, G., Fu, S., Sherman, E., Fein, D., Krop, J., Korth, C., Wang, J., Sharma, M., Spigel, D., Filipovic, A., & Wainberg, Z. (2023). 128P A phase I dose escalation and expansion trial of LYT-200: A galectin-9 antibody +/- tislelizumab. Immuno-Oncology and Technology, 20, 100600. https://doi.org/10.1016/j.iotech.2023.100600
Publication Date
Qayum, N., Uddin, M. N., Khan, W., Un Nabi, H., Taj-Ud-Din, Suleman, M., Ur Rahman, H., Ali, I., Hassan deif, A., Almeer, R., & Ullah, F. (2023). The outbreak of migratory goat’s brucellosis in the Swat ecosystem of Khyber Pakhtunkhwa. Onderstepoort Journal of Veterinary Research, 90(1). https://doi.org/10.4102/ojvr.v90i1.2079
Publication Date
Ma, L., Liu, Y., Wang, Y., Yang, J., Lu, J., Feng, H., Ye, S., & Liu, Y. (2023). Identification of PTPN20 as an innate immunity-related gene in gastric cancer with Helicobacter pylori infection. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1212692
Publication Date
Liang, L. W., Hasegawa, K., Maurer, M. S., Reilly, M. P., Fifer, M. A., & Shimada, Y. J. (2023). Comprehensive Transcriptomics Profiling of MicroRNA Reveals Plasma Circulating Biomarkers of Hypertrophic Cardiomyopathy and Dysregulated Signaling Pathways. Circulation: Heart Failure, 16(6). https://doi.org/10.1161/circheartfailure.122.010010
Publication Date
Van Nieuwenhuysen, E., O’Malley, D., O’Cearbhaill, R. E., Moore, K. N., Hamilton, E. P., Yeku, O., Bouberhan, S., Hou, J. Y., Yoo, S.-Y., Brouwer-Visser, J., Cheung, H. K., Peterman, M., Goncalves, P., Schmidt, T., Zhu, M., Lowy, I., Rowlands, T., Uldrick, T. S., Miller, E. A., & Liu, J. F. (2022). 523MO Ubamatamab (REGN4018, MUC16xCD3 bispecific antibody) monotherapy in patients with recurrent ovarian cancer (OC): Phase I dose-escalation analysis. Annals of Oncology, 33, S784. https://doi.org/10.1016/j.annonc.2022.07.651
Publication Date
Palrasu, M., Zaika, E., Paulrasu, K., Caspa Gokulan, R., Suarez, G., Que, J., El-Rifai, W., Peek, R. M., Garcia-Buitrago, M., & Zaika, A. I. (2022). Helicobacter pylori pathogen inhibits cellular responses to oncogenic stress and apoptosis. PLOS Pathogens, 18(6), e1010628. https://doi.org/10.1371/journal.ppat.1010628
Publication Date
Ambrosini, G., Rai, A. J., Carvajal, R. D., & Schwartz, G. K. (2022). Uveal Melanoma Exosomes Induce a Prometastatic Microenvironment through Macrophage Migration Inhibitory Factor. Molecular Cancer Research, 20(4), 661–669. https://doi.org/10.1158/1541-7786.mcr-21-0526
Publication Date